Univo Pharmaceuticals (XTAE:UNVO-M) LT-Debt-to-Total-Asset : 0.39 (As of Jun. 2022)

View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Univo Pharmaceuticals's long-term debt to total assests ratio for the quarter that ended in Jun. 2022 was 0.39.

Univo Pharmaceuticals's long-term debt to total assets ratio increased from Jun. 2021 (0.32) to Jun. 2022 (0.39). It may suggest that Univo Pharmaceuticals is progressively becoming more dependent on debt to grow their business.

Univo Pharmaceuticals LT-Debt-to-Total-Asset Historical Data

The historical data trend for Univo Pharmaceuticals's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals LT-Debt-to-Total-Asset Chart

Univo Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.13

0.37

0.29

Univo Pharmaceuticals Quarterly Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial													0.32	0.30	0.29	0.31	0.39

Univo Pharmaceuticals LT-Debt-to-Total-Asset Calculation

Univo Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

LT Debt to Total Assets (A: Dec. 2021 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2021 )	/	Total Assets (A: Dec. 2021 )
	=	29.485	/	101.128
	=	0.29

Univo Pharmaceuticals's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2022 is calculated as

LT Debt to Total Assets (Q: Jun. 2022 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2022 )	/	Total Assets (Q: Jun. 2022 )
	=	29.665	/	75.939
	=	0.39

Univo Pharmaceuticals (XTAE:UNVO-M) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Univo Pharmaceuticals LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Univo Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harshar 20, Ashkelon, ISR, 7878329

Website

https://www.univopharma.com

Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines